Drug Delivery Device Markings for Medication Identification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Drug delivery devices with similar appearances can lead to user confusion, increasing the risk of administering the wrong medication, as visual markings on cartridges may be difficult to distinguish once loaded into the device, and dedicated mechanical coding can complicate assembly, potentially causing damage.

Innovation Solution

The implementation of a set of components for drug delivery devices with substantially equivalent or identical markings, including tactile, color, and text markings, to ensure user identification of the correct drug during operation, with these markings being viewable and contactable at various stages of device use, such as when setting and delivering doses.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of information

If cartridges are marked with medicament details, then drug identification is improved, but the markings become difficult to see after the cartridge is loaded into the device

Engineering Contradiction:
Improvemedicament identification visibilityVSAvoiduser ability to verify drug
Core Design Contradiction:
Loss of informationVSEase of operation

Solution Approach 1:

The patent transfers the medicament identification markings from the cartridge (internal component) to the outer housing of the injection device (external component). This dimensional relocation ensures markings remain visible and accessible to users throughout the device's operation, resolving the visibility problem when cartridges are loaded into devices.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Loss of information

If reusable devices are marked with medicament differentiation, then user identification is improved, but the risk of loading wrong cartridge increases

Engineering Contradiction:
Improvemedicament identificationVSAvoidsafety against wrong drug administration
Core Design Contradiction:
Loss of informationVSReliability

Solution Approach 1:

The patent applies universal markings across all components of the device system (housing, cartridge, cap, plunger). This multi-component marking strategy creates redundant identification points, allowing users to verify medicament identity from multiple locations and reducing the risk of wrong drug administration even if one component is misidentified.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The consistent markings on multiple components provide continuous feedback to the user about the correct drug being administered. Users can verify the markings at different stages (assembly, preparation, administration), creating multiple opportunities to catch potential errors before wrong drug administration occurs.

Inventive Principle:
Principle #23Feedback

3Manufacturing precision

If all detachable parts are dedicated or mechanically coded, then assembly accuracy is improved, but the device becomes difficult to understand and may cause excessive force application

Engineering Contradiction:
Improvecomponent assembly accuracyVSAvoiduser understanding of assembly
Core Design Contradiction:
Manufacturing precisionVSEase of operation

Solution Approach 1:

The patent employs color markings on device components to provide visual cues about correct assembly and component identification. These color indicators work alongside mechanical coding to guide users through the assembly process without requiring complex mechanical features, reducing the likelihood of excessive force application and improving overall understandability.

Inventive Principle:
Principle #32Color changes

Data Source

PatentUS10207056B2Set of members for a drug delivery device, drug delivery device and set of drug delivery devices
Publication Date: 2019.02.19 AUTO INJECTION TECH LLC
  • US10207056B2 patent drawing
  • US10207056B2 patent drawing
  • US10207056B2 patent drawing

AI summary

A set of members for a drug delivery device comprises at least two components for the device, wherein both components are provided with a marking, the markings being substantially equivalent or identical. Furthermore, a drug delivery device and a set of drug delivery devices are provided.